Cubist Systematic Strategies’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-800
| Closed | -$5K | – | 4212 |
|
|
2022
Q2 | $5K | Buy |
800
+432
| +117% | +$2.7K | ﹤0.01% | 3758 |
|
|
2022
Q1 | $2K | Buy |
+368
| New | +$2K | ﹤0.01% | 3495 |
|
|
2021
Q3 | – | Sell |
-328
| Closed | -$2K | – | 3336 |
|
|
2021
Q2 | $2K | Buy |
+328
| New | +$2K | ﹤0.01% | 2891 |
|
|
2017
Q2 | – | Sell |
-1,874
| Closed | -$45K | – | 2019 |
|
|
2017
Q1 | $45K | Sell |
1,874
-821
| -30% | -$19.7K | ﹤0.01% | 1487 |
|
|
2016
Q4 | $87K | Buy |
+2,695
| New | +$87K | 0.01% | 1517 |
|
|
2016
Q3 | – | Sell |
-3,194
| Closed | -$135K | – | 1995 |
|
|
2016
Q2 | $135K | Buy |
3,194
+1,905
| +148% | +$80.5K | 0.01% | 1447 |
|
|
2016
Q1 | $85K | Sell |
1,289
-587
| -31% | -$38.7K | ﹤0.01% | 1421 |
|
|
2015
Q4 | $117K | Buy |
+1,876
| New | +$117K | 0.01% | 1483 |
|
|
2015
Q2 | – | Sell |
-1,753
| Closed | -$164K | – | 2192 |
|
|
2015
Q1 | $164K | Buy |
+1,753
| New | +$164K | 0.01% | 1588 |
|
|
2014
Q3 | – | Sell |
-4,280
| Closed | -$246K | – | 1965 |
|
|
2014
Q2 | $246K | Buy |
+4,280
| New | +$246K | 0.01% | 1052 |
|